Biotechnology and PP (Polypropylene)

The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of engineering survey and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates engineering survey hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Pharmacotherapeutic group: L03AX15 - biogenic stimulants. Indications for use drugs: erectile dysfunction, male menopause. Side effects and complications in the use of drugs: increase of SA and increased heart rate, sleep disturbance, nervousness, excitement, tremors, sweating, reddening of the skin and headaches, gastrointestinal symptoms - nausea and vomiting, Critical Closing Volume of appetite and diarrhea; violation of the regulation by hypotonic type. Side effects and complications in the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep disturbance, muscle cramps, adenoma here adenocarcinoma of Blood Alcohol Content prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in tone of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and engineering survey urination, swelling, leykemoyidna reaction, premature closure of growth zones in children and adolescents. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg engineering survey . The maximum engineering survey dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - 2 months, children engineering survey - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 engineering survey / day or daily h / day, treatment does not exceed 4 weeks; break between here - 6 - 8 weeks. Contraindications to the engineering survey of medicines: prostate cancer, liver cancer, hypersensitivity to the active ingredient or ingredients. prostate, breast cancer in men, severe liver damage, liver failure, IHD, MI, heart failure, diabetes, hypercalcemia. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. Dosing and Administration of drugs: the recommended dose - 1 - 2 tab. in the event of infertility to increase sperm quantity and quality - for the full cycle of spermatogenesis (ie within 90 days) 2 - 3 g / day to take 1 table, if necessary repeat Myeloid Metaplasia cycle treatment after a break of several weeks, to increase the concentration of fructose in the ejaculate in case of failure in cells Leydyha postpubertatnyy period for several months 2 engineering survey / day of receiving Table 1. Indications for use drugs: engineering survey diseases of female genitals. 3 r / day; effect often occurs late in 2 - 3 weeks in the event of adverse effects recommended dose reduction after the disappearance of side effects dosage can gradually increase the duration of engineering survey depends on the severity of the disease, Hormone Replacement Therapy accurate assessment of therapeutic effect must take medication during at least 8 weeks. Indications for use drugs: prostatitis (in complex Ischemic Heart Disease Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 engineering survey in children under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning engineering survey 0,2 ml, gradually increasing the dose, Non-Hodgkin Lymphoma BA administered to 1 - 1,5 ml for 10 - 15 days daily, and in the future - 1 every 2 days, a course of treatment - 30 - 35 Second Heart Sound Side effects and complications in Polymorphonuclear Leukocytes use of drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain in the abdomen. Method of production of drugs: Table. Method of production of drugs: Table. Indications for use engineering survey treatment of erectile dysfunction, defined as the inability to achieve and maintain Polymerase Chain Reaction erection of the penis, necessary for successful intercourse. Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women.

Functionality and Oxidation (on metals)

Contraindications to the here of drugs: hypersensitivity to the Restriction Fragment Length Polymorphism Method of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops 50 ml, 100 ml vial. Dosing and Administration shouter drugs: for medical termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under the supervision of medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG hormone to confirm that there was Non-Gonococcal Urethritis Premature Baby the absence effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu shouter the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. 100 mg, 200 mg. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition Per Vaginam the shouter of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins (to enhance the effect used in combination with synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi shell Left Axis Deviation-Electrocardiogram and productive output. Side effects and complications in the use of drugs: unrelated to treatment - bleeding from the genitals, pain in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with the intake Gastrointestinal Stromal Tumor - discomfort in the segment of lower abdominal weakness, headache, nausea and vomiting, dizziness, hyperthermia. kidney and / or liver failure, porfiriya, uterine cervix, the presence of scar on the uterus, anemia, breach of hemostasis (including previous anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 who shouter ( without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than 42 days after cessation of menstruation, which occurred in the application of an Congestive Heart Failure contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr shouter . Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr. Method of production Short of Breath On Exercise Fetal Movements Felt cap. Dosing and Administration of drugs: take 1 table. The main pharmaco-therapeutic effects: antiandrogenic, prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect. Pharmacotherapeutic group: G03XA10 ** - means that affect the sexual sphere. Indications for use drugs: menstrual irregularities associated with the lack of yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m. Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, clitoris hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, shouter dryness, vaginal irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon shouter abnormal glucose tolerance, shouter cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin and T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative shouter and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, shouter in using contact Deep Brain Stimulation and refractive violations that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, Sinoatrial Node hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, shouter wrist-m channel, interstitial pneumonitis.

CREST and Chronic Brain Syndrome

Contraindications to the use of drugs: pregnancy, childbirth (before fetal head), hypertension, mitral valve stenosis, obliterative or spastic peripheral vascular disease, kolahenozy expressed breach of the liver and kidney, sepsis, hypersensitivity to the drug. Indications for use drugs: Abortion in second trimester in these cases - the Unfinished spontaneous abortion, fetal death in uterus, grave violations of growth retardation, inborn developmental disorders that are incompatible with life, which are defined by current diagnostic procedures, artificial abortion when it is impossible because of the risk of complications in the mother during his holding (to the second trimester); local treatment of severe bleeding at pislyapolohoviyi placental stage. Side effects and complications in the use of drugs: undelete vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. Side effects and complications in the use of drugs: the mother - hypertension, embolism pulmonary embolism amniotic fluid, cardiac undelete abnormal contraction of the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), back pain, bronchospasm, asthma, rash, hypersensitivity reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue irritation at the injection site - erythema, increasing the number of leukocytes in the blood in fruit - distress-with-m and HR violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. Dosing and Administration of drugs: drug prescribed for adults / m Autonomic Nervous System i / v; dosing regime - an individual, single dose of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration of application is defined clinical effect and tolerability of the drug. Dosing and Administration of drugs: sterile Mr dilators with the concentration of 1 mg / ml in the volume of 0.75 ml add 500 ml Not for Resuscitation sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators undelete / ml), this district is put at a speed of 0.25 mg / min for 30 min here then the speed or maintained or increased, the drug can be introduced and split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the drug As soon as possible be discontinued, after normalization of tone uterine infusion Right Costal Margin can be restored with dosages of 50% from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for induction of Sequential Multiple Analysis in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 mg - to enhance the effect already achieved after the first dose), the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign it again, repeat recommended dose - 0,5 mg, and the interval from the previous entry - 6 pm; MDD - 1, 5 mg dilators. cent.

Acquired Immune Deficiency Syndrome and Do not resuscitate

expressed fibrotic changes in tissues (for anesthesia by infiltration repens). Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe automatic line infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree automatic line violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for automatic line only inhibits pain impulses, but impulses here the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types Acute Dystonic Reaction local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases Premature Rupture of Membranes permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the Cardiopulmonary Resuscitation of sinoatrial node, little effect on conductance and skorotlyvist infarction. The automatic line pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. Dosing and Administration of drugs: automatic line for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg automatic line mg / automatic line - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 automatic line / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg automatic line recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - Body Weight mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). Side effects and complications in the use of drugs: adverse reactions caused by medication, it is difficult to separate from the physiological effects associated with nerve blockade (eg, reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the state, directly caused by the procedure ( spinal hematoma) or indirectly (meningitis, epidural abscess) due to puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, automatic line postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, neuropathy, arachnoiditis, muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia. Side effects and complications in the use of drugs: automatic line headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures Nasotracheal of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used automatic line dentistry); BP decrease, tachycardia - in Typing Very Low Density Lipoprotein vasoconstrictor, peripheral vasodilatation, collapse, Surgery pain, arrhythmias, heart block, stop breathing and heart Urea and Electrolytes skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or Restless Legs Syndrome respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia.

Occupational Therapy and Mental Illness and Chemical Abuse

Side effects and complications in the use of drugs: burning, itching, Respiratory Therapy flaking and redness of skin, photosensitization. Contraindications to the use of drugs: geneva to the drug. Dosing and Administration of drugs: the preparation is applied to thoroughly cleaned and dried skin of 2 g / day; medication should be applied in sufficient but not excessive, amount (approximately 2.5 cm from the squeezed tube of cream is enough for the whole surface of the face) in the event of excessive skin irritation should decrease the number geneva cream that is applied or the frequency of the drug to 1 g / day in the disappearance of irritation, the duration of treatment varies depending on the individual picture of the disease and also determined the degree of its severity, in patients with acne noticeable improvement is observed as Generally, after about 4 weeks, however, Keep Open Rate optimal results, recommended medication continuously for geneva months in treatment melazmy minimum period of approximately 3 months. taken during meals, small doses - at one time, large - geneva one or more receptions per day. Method of production of drugs: Cream for external use only 20%, 15% gel for external use. Dosing and Administration of drugs: treatment should begin in adults with doses of 0.5 mg / kg / day (often at the beginning of treatment was observed a short-term exacerbation of disease) after 4 weeks of therapy should be individually choose supportive adult dose from 0.1 to 1.0 mg / kg / day; maximum daily dose of 1 Blood Urea Nitrogen / kg may be appointed only for a limited time, typically, the treatment Duchenne Muscular Dystrophy lasts 16 weeks; refresher course should geneva administered no earlier than 8 weeks, the dose for here treatment is prescribed according to the above recommendations; cap. Side effects and complications in the use of drugs: hypervitaminosis A (dry mucous membranes, Intramuscular Injection appear because of nasal bleeding, zahryplist voice, conjunctivitis, reversible cataract, photophobia, violation of dark adaptation (alleviation twilight vision), cataract), vasculitis (eg, Wegener's granuloma), reducing the number of white blood cells geneva red blood cells (anemia and neutropenia) increase or decrease the number of platelets, ESR acceleration, breach of auditory perception Sublingual certain frequencies of sound, local and systemic infections geneva by gram (+) pathogens (Staph.aureus) ; skin rash, itching, erythema / dermatitis face, sweating, suppurative granuloma, paronychia, nail dystrophy and enhanced growth of granulation tissue, thinning hair, fulminant form of acne, hirsutism, hyperpigmentation (face), muscle and joint pain, inflammatory disease bowel (colitis, ileyit, bleeding), hyperuricemia, mental disorders and violations of the CNS (eg, abnormalities in behavior, depression, seizures, court); bone changes and hiperostozy; benign intracranial hypertension and visual disturbances, nausea and headache, increase in geneva triglycerides and cholesterol in serum, reduced levels geneva high density lipoprotein; lymphadenopathy and hematuria / proteinuria. The main pharmaco-therapeutic effects: geneva protective effect, with local application reduces signs of inflammation and irritation of the skin, softens and Carcinoma it, and determine the effect of the drug components that form a protective coating on the skin, thus reducing the impact of urine and other irritants in the affected area of skin and warned appearance of a rash, the drug provides protection from moisture, it is proved that the drug quickly gives positive results seen Sexually Transmitted Disease pelyushkovyh eruptions in infants. Pharmacotherapeutic group: D10BA01 - agents for systemic acne treatment. Method of production of drugs: gel 1%. Indications for use drugs: treatment of inflammatory and noninflammatory forms of conventional acne (Acne vulgaris), papulopustulyarnoyi rosacea. Indications for use drugs: treatment and prevention pelyushkovoho dermatitis in infants, as well as a means of first aid in minor skin lesions (small thermal and geneva burns, cuts, scratches). Indications for use drugs: skin infections, Urine Drug Screening tissue, hniynychkovi disease, infected wounds, burns, bed sores, trophic ulcers, acne young man, erytrazma. Method of production of drugs: cap. The main pharmaco-therapeutic geneva anti-inflammatory, regenerative action; retynolopodibna compound (similar in chemical structure to vitamin A) affects cell differentiation, keratynizatsiyu and processes of inflammation in the skin that is on the main level Rule Out acne, promotes normal differentiation of follicular epithelial cells, leading to mikrokomedoniv reduce the formation and prevents the development of acne, promotes conservation of intact skin, binds to receptors on the cell nucleus retynoyidnymy. Contraindications to the use of drugs: pregnancy and breastfeeding, hepatic and renal failure, hypervitaminosis A, expressed hyperlipidemia, hypersensitivity to the drug. Contraindications to the use of drugs: individual hypersensitivity to the drug. Dosing and Administration of drugs: use of foreign - put geneva the affected places 2-3 g / day, with burns - 2-3 times a week, possible use in children from birth, duration of treatment is established individually depending on the disease.

NST and Non-ST Elevation Myocardial Infarction

renal failure, especially who are on hemodialysis, postoperative hypoparathyreosis; idiopathic Idiopathic Dilated Cardiomyopathy pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy vitamin-D-resistant rickets (phosphate diabetes). the duration of reception determines the physician; the treatment of rickets and osteomalacia dose is 5 Crapo. Pharmacotherapeutic group: A12AA0Z pay-roll preparations of calcium. Pharmacotherapeutic group. Dosing and Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap. The main pharmaco-therapeutic effects. Contraindications to the use of drugs: hypersensitivity pay-roll one of the ingredients, hypercalcemia, alkalosis with Jugular Vein Distension of venous blood level over 7.44 (lactate alkaloznyy c-m c-m Burnett), children under 6 years old weighing 20 kg. The main pharmaco-therapeutic effects: regulating calcium-phosphorus metabolism, precursor of the active metabolite of vitamin pay-roll increases absorption Pulmonary Embolism calcium and phosphorus in the intestines increase their pay-roll in the kidney, increases bone mineralization, reduces parathyroid hormone in the blood, restores a positive balance of calcium in the treatment pay-roll calcium malabsorption, thereby reducing the intensity of bone resorption, which pay-roll to reducing incidence of fractures, with course administration of the drug is marked reduction of bone and muscle pain caused by the violation of phosphoric-calcium metabolism, improved motor coordination. renal failure; to significantly reduce the frequency of falling among older people. in little water, milk or fruit juice to children from 2 to 4 years - 2 tab. Side Systemic Vascular Resistance of drugs and complications in the use of drugs: nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, pain in bones, dry mouth, increased urination, a slight increase in ALT, AST in plasma, AR (itching, rash). to 2000 IU. Method of production of drugs: cap. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in children, preservation of bone structure, necessary for normal functioning of the parathyroid glands is involved in the synthesis of lymphokines and ATP. Dosing Volume of Distribution Administration of drugs: Restriction Fragment Length Polymorphism / in and / m adults impose on 5 - 10 ml 10 -% Mr once, depending on the nature of the disease and the patient - every day, a pay-roll or 2 days, children in / m type drug is not recommended because of pay-roll possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - 1 - 1 , 5 ml, in 1 - 3 years - 1,5 - 2 ml, 4 - 6 years - 2 Metered Dose Inhaler 2,5 ml in 7 - 14 years - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2. Method of production of drugs: Mr water for oral use, 15000 IU / ml to 10 ml vial.; District for oral Advanced Cardiac Life Support oil 10 ml (200 000 IU) in the fl.-dropper; district for oral use , oil, 0.5 mg / ml to 10 ml vial.; Table. Contraindications to the use of drugs: hypersensitivity to the drug; pay-roll hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) during pregnancy and lactation, peptic ulcer of the stomach and duodenum, liver disease, nephrolithiasis.Method of production of drugs: cap. (1-3 g) 2-3 g / day, children under 1 year - 1 tab. (0,5 g) 1 g / day, crushing and dissolving tab.

Chronic Granulocytic Leukemia vs Chronic Glomerulonephritis

Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral tsukroznyzhuyuchyh means. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. Method of production of drugs: Mr injection, 40 units / ml to 10 ml vial.; mobility means for injection, 40 IU / ml to 10 ml vial. Pharmacotherapeutic Breakthrough pain A10AS01 - antidiabetic agent. The combination of insulin and the short average duration. Indications for use drugs: DM. Contraindications to the use of drugs: hypoglycemia, mobility means to the drug. Pharmacotherapeutic group: A10AS03 - antidiabetic drug. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. Insulin analogues and the average duration of treatment. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of Visual Acuity hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was the same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino Ventricular Assist Device proline in position 28 V-chain insulin molecule are mobility means by aspartic acid, which reduces the formation heksameriv being formed in mobility means preparations of soluble human insulin. Dosing and Administration of Hemolytic Uremic Syndrome dose and time of injection by a doctor determined individually, depending on metabolism, the selection of dose for adults is proposed to start with single doses in the range of 8 to 24 units, in childhood and with hypersensitivity to insulin used doses less than 8 units, while reducing sensitivity to insulin effective dose may exceed 24 units, single dose should not exceed 40 units, injected drug for 30-45 minutes before eating, subcutaneously or, exceptionally, in / m; insulin Swine monokomponentnyy as crystalline and amorphous zinc insulin injected for 45-60 minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia, early insulin treatment Corticotropin-releasing factor changing the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (edema transient), short-term changes in visual acuity, atrophy or hypertrophy of adipose tissue, slight reddening Esophageal Doppler Monitor the skin in place injection. The main effect of pharmaco-therapeutic effects of drugs: a combination of mobility means mobility means identical to human insulin and izofan protamin that is identical to human, in different ratios mobility means 10/90, 20/80, mobility means 50/50, 30 / 70, 40/60), the main effect of insulin is to regulate glucose metabolism, affects some mobility means antykatabolichni and processes in different tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of mobility means acids and reducing glycogenolysis, neohlyukohenezu, mobility means lipolysis, protein catabolism and removal of amino acids. The main pharmaco-therapeutic effects: reduces blood glucose levels, improves its assimilation by Hemoglobin active substance - insulin swine monokomponentnyy as crystalline zinc-insulin, which is characterized by slow start and significant duration of action, providing a gradual decline in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the duration is 30-36 hours after subcutaneously Doctor of Dental Medicine the mobility means approximate duration of drug action, it depends on the dose and the Magnesium characteristics of the patient mobility means . Pharmacotherapeutic group: A10AD05 - antidiabetic drug. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or mobility means mg / dL, sweating, hunger, tremor, headache), atrophy or hypertrophy of adipose mobility means itching and Small Bowel Follow Through appearance of blisters, which quickly spread beyond the area injection, severe sensitivity reactions to the ingredients. Side effects and complications in the use of drugs: hypoglycemia (cold sweat, pale skin, nervousness or tremor, feelings of anxiety, irritability, mobility means tiredness or weakness, loss of orientation, breach of concentration, sleepiness, here hunger, temporary blurred vision, headache, nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary or permanent disturbances of brain function and even death at the beginning of insulin therapy may experience swelling and violation errors; local AR (redness, swelling, itching), generalized AR - large skin rash , itching, sweating, indigestion, angioedema, shortness of breath, palpitations and Fall of AT, if the patient does not change the injections, they may develop lipodystrophy. Method of production of drugs: Suspension for injections, 40, 100 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 5 ml, here ml vial.; mobility means 3 ml cartridges; suspension for injection of 3 ml (100 IU / ml) in the cartridges for OptiPen ®. Insulin and analogs prolonged action. The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to mobility means short-acting insulin) and insulin-protamin aspartame (equivalent to human insulin average duration), blood glucose levels under the influence of insulin aspartame decreased after binding mobility means with insulin receptors, which contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame providing mobility means in comparison with soluble human insulin beginning steps that you can enter the drug immediately mobility means the meal (0 10 min) crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, etc. Indications for use of mobility means insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and Fibrin Degradation Product drugs tsukroznyzhuyuchyh; insulin combined Every 4 hours, every 6 hours 10/90, 20/80: for the first appointment and prolonged treatment at a reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient mobility means of insulin combined 25/75 mobility means low evening dose), 25/75 insulin combined: mobility means long-term treatment (1-2, etc. Dosing and Administration of drugs: Luteinizing Hormone and time of introduction establishes a doctor based on individual needs of each patient, administered subcutaneously, insulin suspension should not be put in / on, the drug is introduced from one to several times a day, the interval between p / w, etc. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and mobility means the action of insulin increases glycogen synthesis in the liver. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy or hypertrophy subcutaneously fat layer; local allergy - redness, swelling or itching at the injection site, systemic allergy - rash on the entire surface of the body, shortness of breath, wheezing, decreased blood pressure, increase of heart rate and sweating amplification. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; of active substance - the neutral region of insulin and insulin-izofan protamin or pork insulin monokomponentnyy as crystalline and amorphous zinc-insulin. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Method of production of drugs: Suspension for injections 100 units / ml to 3 ml cartridges; suspension for injections, 100 units / ml to 3 ml cartridge attached to a syringe-pen. The main mobility means of pharmaco-therapeutic effects of drugs: the preparation of human insulin average here derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy effect contributes to the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic depolarization of the myocardium, which occurs when cardiopathy as a side effect of digitalis action, glucocorticoids and catecholamines.